RMD 1301
Alternative Names: RMD-1301Latest Information Update: 01 Oct 2021
At a glance
- Originator Remedium Bio
- Class Gene therapies; Heart failure therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Myocardial infarction
Most Recent Events
- 01 Oct 2021 Early research in Myocardial infarction in USA (IV) prior to October 2021 (Remedium Bio pipeline, October 2021)